Evidence map›Paper›PMID 34281288›Full record

ArticleInternational journal of molecular sciences2021

The Lrat

Céline Koster, Koen T van den Hurk, Colby F Lewallen, Mays Talib, Jacoline B Ten Brink, Camiel J F Boon, Arthur A Bergen

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Towards an Understanding of Retinal Diseases and Novel Treatment.International journal of molecular sciences · 2022
    Article
  6. Genetic dissection of non-syndromic retinitis pigmentosa.Indian journal of ophthalmology · 2022
    Review
  7. Article
  8. Recent Advances in the Production of Genome-Edited Rats.International journal of molecular sciences · 2022
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Céline KosterDepartment of Human Genetics Amsterdam, Section of Ophthalmogenetics, Amsterdam University Medical Centers (AUMC), University of Amsterdam (UvA), Location Meibergdreef, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-0936-3970
Koen T van den HurkDepartment of Human Genetics Amsterdam, Section of Ophthalmogenetics, Amsterdam University Medical Centers (AUMC), University of Amsterdam (UvA), Location Meibergdreef, 1105 AZ Amsterdam, The Netherlands.
Colby F LewallenGeorgia Institute of Technology, G.W. Woodruff School of Mechanical Engineering, Atlanta, GA 30313, USA.ORCID 0000-0002-4424-2533
Mays TalibDepartment of Ophthalmology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Jacoline B Ten BrinkDepartment of Human Genetics Amsterdam, Section of Ophthalmogenetics, Amsterdam University Medical Centers (AUMC), University of Amsterdam (UvA), Location Meibergdreef, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0001-7884-0067
Camiel J F BoonDepartment of Ophthalmology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Arthur A BergenDepartment of Human Genetics Amsterdam, Section of Ophthalmogenetics, Amsterdam University Medical Centers (AUMC), University of Amsterdam (UvA), Location Meibergdreef, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-6333-9576
Amsterdam University Medical Centers · NLLeiden University Medical Center · NLGeorgia Institute of Technology · USNetherlands Institute for Neuroscience · NL

Funding

Rotterdamse Stichting Blindenbelangen B20160043Stichting BlindenhulpStichting Lijf en Leven 42Stichting Uitzicht including the Stichting MD Nederland, Landelijke Stichting voor Blinden en Slechtzienden, Stichting Retina Fonds Nederland, Oogfonds UZ 2016 - 21Stichting voor Ooglijders
6 · The paper itself

Abstract

purposeWe developed and phenotyped a pigmented knockout rat model for lecithin retinol acyltransferase (LRAT) using CRISPR/Cas9. The introduced mutation (c.12delA) is based on a patient group harboring a homologous homozygous frameshift mutation in the

methodsThe introduced mutation was confirmed by DNA and RNA sequencing. The expression of

resultsWildtype animals had high

conclusionsOur

Indexed as

AcyltransferasesAnimalsBehavior, AnimalCRISPR-Cas SystemsDisease Models, AnimalElectroretinographyFemaleGene Knockout TechniquesHumansMaleMiceOphthalmoscopyRatsRats, TransgenicRetinitis PigmentosaRNA, MessengerAcyltransferaseslecithin-retinol acyltransferaseRNA, Messengerlecithin retinol acyltransferase (LRAT)pigmented rat modelretinal degenerationretinal dystrophyretinal pigment epithelium (RPE)retinitis pigmentosa

Identifiers

PMID34281288
PMCPMC8267968
OpenAlexW3181802209

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.